GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 64 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 52 | |
P/E GROWTH RATING 1..100 | 30 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FLGB | GSK | |
---|---|---|
RSI ODDS (%) | 1 day ago74% | 1 day ago51% |
Stochastic ODDS (%) | 1 day ago79% | 1 day ago45% |
Momentum ODDS (%) | 1 day ago78% | 1 day ago44% |
MACD ODDS (%) | 1 day ago77% | 1 day ago69% |
TrendWeek ODDS (%) | 1 day ago83% | 1 day ago60% |
TrendMonth ODDS (%) | 1 day ago80% | 1 day ago53% |
Advances ODDS (%) | 1 day ago83% | 5 days ago59% |
Declines ODDS (%) | 8 days ago74% | N/A |
BollingerBands ODDS (%) | 1 day ago90% | 1 day ago53% |
Aroon ODDS (%) | 1 day ago79% | 1 day ago46% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ASA | 40.47 | 0.92 | +2.33% |
ASA Gold AND Precious Metals Limited | |||
ITOT | 142.30 | 0.40 | +0.28% |
iShares Core S&P Total US Stock Mkt ETF | |||
PBAU | 29.09 | 0.04 | +0.13% |
PGIM S&P 500 Buffer 20 ETF - Aug | |||
IHY | 22.15 | 0.02 | +0.09% |
VanEck Intl Hi Yld Bd ETF | |||
UJUL | 37.69 | 0.03 | +0.07% |
Innovator U.S. Equity Ultra BffrETF™-Jul |
A.I.dvisor tells us that FLGB and RIO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FLGB and RIO's prices will move in lockstep.
Ticker / NAME | Correlation To FLGB | 1D Price Change % | ||
---|---|---|---|---|
FLGB | 100% | +0.19% | ||
RIO - FLGB | 26% Poorly correlated | -0.39% | ||
NG - FLGB | 25% Poorly correlated | -0.44% | ||
GSK - FLGB | 24% Poorly correlated | -1.11% | ||
VOD - FLGB | 20% Poorly correlated | -0.08% | ||
HLN - FLGB | 20% Poorly correlated | -0.61% | ||
More |
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with AZN. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then AZN could also see price increases.